MediPharm Labs (LABS) Competitors C$0.06 0.00 (0.00%) As of 09:40 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock LABS vs. HLS, SUGR, TGOD, NINE, MDP, WMD, VM, WLLW, HEXO, and VIRShould you be buying MediPharm Labs stock or one of its competitors? The main competitors of MediPharm Labs include HLS Therapeutics (HLS), SugarBud Craft Growers (SUGR), Green Organic Dutchman (TGOD), Delta 9 Cannabis (NINE), Medexus Pharmaceuticals (MDP), WeedMD (WMD), Voyageur Pharmaceuticals (VM), Willow Biosciences (WLLW), HEXO (HEXO), and Viridium Pacific Group (VIR). These companies are all part of the "drug manufacturers - specialty & generic" industry. MediPharm Labs vs. Its Competitors HLS Therapeutics SugarBud Craft Growers Green Organic Dutchman Delta 9 Cannabis Medexus Pharmaceuticals WeedMD Voyageur Pharmaceuticals Willow Biosciences HEXO Viridium Pacific Group HLS Therapeutics (TSE:HLS) and MediPharm Labs (TSE:LABS) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, media sentiment, dividends, earnings, institutional ownership and risk. Do insiders and institutionals hold more shares of HLS or LABS? 65.2% of HLS Therapeutics shares are owned by institutional investors. Comparatively, 0.7% of MediPharm Labs shares are owned by institutional investors. 0.4% of HLS Therapeutics shares are owned by insiders. Comparatively, 4.5% of MediPharm Labs shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Do analysts rate HLS or LABS? HLS Therapeutics presently has a consensus price target of C$4.50, suggesting a potential downside of 8.16%. Given HLS Therapeutics' stronger consensus rating and higher probable upside, equities research analysts plainly believe HLS Therapeutics is more favorable than MediPharm Labs.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HLS Therapeutics 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00MediPharm Labs 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is HLS or LABS more profitable? MediPharm Labs has a net margin of -30.56% compared to HLS Therapeutics' net margin of -38.70%. MediPharm Labs' return on equity of -24.41% beat HLS Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets HLS Therapeutics-38.70% -25.27% -2.89% MediPharm Labs -30.56%-24.41%-7.17% Does the media prefer HLS or LABS? In the previous week, HLS Therapeutics' average media sentiment score of 0.00 equaled MediPharm Labs'average media sentiment score. Company Overall Sentiment HLS Therapeutics Neutral MediPharm Labs Neutral Which has preferable valuation & earnings, HLS or LABS? MediPharm Labs has lower revenue, but higher earnings than HLS Therapeutics. HLS Therapeutics is trading at a lower price-to-earnings ratio than MediPharm Labs, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHLS TherapeuticsC$40.13M2.72-C$15.53M-C$1.00-4.91MediPharm LabsC$39.42M0.68-C$12.05M-C$0.03-2.24 Which has more risk and volatility, HLS or LABS? HLS Therapeutics has a beta of 1.07, indicating that its stock price is 7% more volatile than the S&P 500. Comparatively, MediPharm Labs has a beta of 0.88, indicating that its stock price is 12% less volatile than the S&P 500. SummaryHLS Therapeutics beats MediPharm Labs on 7 of the 13 factors compared between the two stocks. Get MediPharm Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for LABS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LABS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LABS vs. The Competition Export to ExcelMetricMediPharm LabsDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$26.98MC$2.16BC$5.53BC$6.18BDividend YieldN/A2.92%5.25%6.72%P/E Ratio-2.244.1727.0254.57Price / Sales0.68558.81431.591,154.91Price / Cash1.3010.3536.8283.29Price / Book0.5911.708.074.65Net Income-C$12.05MC$21.15BC$3.17BC$301.20M7 Day PerformanceN/A1.71%3.83%0.61%1 Month PerformanceN/A6.38%3.56%3.49%1 Year PerformanceN/A3.98%34.27%27.37% MediPharm Labs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LABSMediPharm LabsN/AC$0.07flatN/A-7.1%C$26.98MC$39.42M-2.24130HLSHLS Therapeutics0.4452 of 5 starsC$4.80+0.2%C$4.50-6.3%+39.0%C$106.79MC$40.13M-4.8191High Trading VolumeSUGRSugarBud Craft GrowersN/AC$13.40+1.1%N/A+73.3%C$91.39MC$575.64M16.1444News CoverageGap DownTGODGreen Organic DutchmanN/AN/AN/AN/AC$89.95MC$31.37M-0.6541Gap UpHigh Trading VolumeNINEDelta 9 CannabisN/AC$1.03+3.0%N/A+0.0%C$89.36MC$12.87M19.07940Gap UpMDPMedexus Pharmaceuticals1.873 of 5 starsC$3.17+0.6%C$5.49+73.1%+20.4%C$70.97MC$100.25M15.1698WMDWeedMDN/AC$0.28-1.8%N/A+0.0%C$67.82MC$27.53M-0.66628Gap UpVMVoyageur PharmaceuticalsN/AC$0.33-2.9%N/A+480.0%C$50.00MN/A-30.87N/AWLLWWillow BiosciencesN/AC$0.30+11.1%N/A+125.0%C$43.45MC$2.94M-5.4919Gap UpHEXOHEXON/AN/AN/AN/AC$38.72MC$124.10M-0.26690VIRViridium Pacific GroupN/AC$0.38+5.6%N/A+0.0%C$37.52MC$1.09M-2.97580Gap Up Related Companies and Tools Related Companies HLS Therapeutics Competitors SugarBud Craft Growers Competitors Green Organic Dutchman Competitors Delta 9 Cannabis Competitors Medexus Pharmaceuticals Competitors WeedMD Competitors Voyageur Pharmaceuticals Competitors Willow Biosciences Competitors HEXO Competitors Viridium Pacific Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:LABS) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MediPharm Labs Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share MediPharm Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
